オートインジェクターの市場規模：用途・タイプ・エンドユーザー別 - 地域的展望・競合戦略・セグメント予測 (～2033年)

世界のオートインジェクターの市場規模は、2033年にかけてCAGR 16.34%で推移し、418億2,000万米ドルの規模に成長すると予測されています。

オートインジェクターの市場はCOVID-19の恩恵を受けています。COVID-19の流行の結果、自己注射はますます普及し、患者は自分の治療により深く関与し、コントロールできるようになっています。オートインジェクター市場では、注射速度の向上し、治療の不安の管理を可能にする先端技術が復活しています。

当レポートでは、世界のオートインジェクターの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 促進要因・抑制・機会・課題の分析
• COVID-19による市場への影響

第5章 市場変数と見通し

• SWOT分析
• PESTEL分析
• ポーターのファイブフォース分析
• ヒートマップ分析

第6章 競合情勢

• 製造拠点の分布・販売エリア・製品タイプ
• M&A・提携・製品発売・協力

第7章 世界のオートインジェクター市場：用途別

• 世界の市場規模のシェア・予測
• アナフィラキシー
• 多発性硬化症
• 関節リウマチ
• その他

第8章 世界のオートインジェクター市場：タイプ別

• 世界の市場規模のシェア・予測
• 使い捨てオートインジェクター
• 再利用可能オートインジェクター

第9章 世界のオートインジェクター市場：エンドユーザー別

• 世界の市場規模のシェア・予測
• 在宅ケア
• 病院・診療所
• その他

第10章 世界のオートインジェクター市場の予測

• 市場規模・市場シェア

第11章 世界のオートインジェクター市場：用途別

• 市場規模・市場シェアの推移・予測

第12章 世界のオートインジェクター市場：タイプ別

• 市場規模・市場シェアの推移・予測

第13章 世界のオートインジェクター市場：エンドユーザー別

• 市場規模・市場シェアの推移・予測

第14章 世界のオートインジェクター市場：地域別

• 市場規模・市場シェアの推移・予測
  • アフリカ
  • アジア太平洋
  • 欧州
  • 中東
  • 北米
  • 南米

第15章 企業プロファイル

• Abbie
• Amgen
• Bayer
• Becton
• Dickinson and Company
• Eli Lilly
• Novartis
• Teva Pharmaceuticals
• Ypsomed
• その他

第15章 略語リスト

第16章 参考リンク

第17章 総論

第18章 調査範囲

Autoinjectors Market Introduction and Overview

According to SPER market research, 'Autoinjectors Market Size - By Application, By Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Autoinjectors Market is predicted to reach USD 41.82 billion by 2033 with CAGR of 16.34%.

One dose of medication, mostly life-saving medications, is administered via autoinjectors. The main purpose of these spring-loaded autoinjectors is to apply drugs in a secure and safe manner. The auto-injector delivery system has revolutionized the industry and changed people's perceptions. Human growth hormones are administered using self-injectors; insulin was recently supplanted by highly developed autoinjectors. Spring-loaded, single-use, disposable syringes (prefilled syringes) are the most common type of autoinjector.

There has been a noticeable decrease in patients postponing seeking therapy and treatment once the limits were changed. The market for autoinjectors has benefited from COVID-19. Self-injections have become increasingly popular as a result of the COVID-19 pandemic, giving patients greater involvement and control over their care. The market for autoinjectors has seen a resurgence of advanced technologies because they enable improved injection speed and the management of treatment anxiety.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Application, By Type, By End User

Regions covered North America, Europe, Asia - Pacific, Middle East, and Africa, and South America

Companies Covered Abbie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed and various others.

Global Autoinjectors Market Segmentation:

By Application: Based on the Application, Global Autoinjectors Market is segmented as; Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others.

By Type: Based on the Type, Global Autoinjectors Market is segmented as; Disposable Autoinjectors and Reusable Autoinjectors.

By End-User: Based on the End-User, Global Autoinjectors Market is segmented as; Home Care Settings, Hospital and Clinics, and Others.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impact of the Global Autoinjectors Market

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Autoinjectors Market Manufacturing Base Distribution, Sales Area, Type, Application
• 6.2. Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Global Autoinjectors Market

7. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)

• 7.1. Global Autoinjectors Market Value Share and Forecast, By Application, 2024-2033
• 7.2. Anaphylaxis
• 7.3. Multiple Sclerosis
• 7.4. Rheumatoid Arthritis
• 7.5. Others

8. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)

• 8.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
• 8.2. Disposable Autoinjectors
• 8.3. Reusable Autoinjectors

9. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)

• 9.1. Global Autoinjectors Market Value Share and Forecast, By Type, 2024-2033
• 9.2. Home Care Settings
• 9.3. Hospital and Clinics
• 9.4. Others

10. Global Autoinjectors Market Forecast, 2020-2033 (USD Million)

• 10.1. Global Autoinjectors Market Size and Market Share

11. Global Autoinjectors Market, By Application, 2020-2033 (USD Million)

• 11.1. Global Autoinjectors Market Size and Market Share By Application (2020-2026)
• 11.2. Global Autoinjectors Market Size and Market Share By Application (2027-2033)

12. Global Autoinjectors Market, By Type, 2020-2033 (USD Million)

• 12.1. Global Autoinjectors Market Size and Market Share By Type (2020-2026)
• 12.2. Global Autoinjectors Market Size and Market Share By Type (2027-2033)

13. Global Autoinjectors Market, By End User, 2020-2033 (USD Million)

• 13.1. Global Autoinjectors Market Size and Market Share By End User (2020-2026)
• 13.2. Global Autoinjectors Market Size and Market Share By End User (2027-2033)

14. Global Autoinjectors Market, By Region, 2020-2033 (USD Million)

• 14.1. Global Autoinjectors Market Size and Market Share By Region (2020-2026)
• 14.2. Global Autoinjectors Market Size and Market Share By Region (2027-2033)
  • 14.2.1. Africa
  • 14.2.2. Asia - Pacific
  • 14.2.3. Europe
  • 14.2.4. Middle East
  • 14.2.5. North America
  • 14.2.6. South America

15. Company Profile

• 15.1. Abbie
  • 15.1.1. Company details
  • 15.1.2. Financial outlook
  • 15.1.3. Type summary
  • 15.1.4. Recent developments
• 15.2. Amgen
  • 15.2.1. Company details
  • 15.2.2. Financial outlook
  • 15.2.3. Type summary
  • 15.2.4. Recent developments
• 15.3. Bayer
  • 15.3.1. Company details
  • 15.3.2. Financial outlook
  • 15.3.3. Type summary
  • 15.3.4. Recent developments
• 15.4. Becton
  • 15.4.1. Company details
  • 15.4.2. Financial outlook
  • 15.4.3. Type summary
  • 15.4.4. Recent developments
• 15.5. Dickinson and Company
  • 15.5.1. Company details
  • 15.5.2. Financial outlook
  • 15.5.3. Type summary
  • 15.5.4. Recent developments
• 15.6. Eli Lilly
  • 15.6.1. Company details
  • 15.6.2. Financial outlook
  • 15.6.3. Type summary
  • 15.6.4. Recent developments
• 15.7. Novartis
  • 15.7.1. Company details
  • 15.7.2. Financial outlook
  • 15.7.3. Type summary
  • 15.7.4. Recent developments
• 15.8. Teva Pharmaceuticals
  • 15.8.1. Company details
  • 15.8.2. Financial outlook
  • 15.8.3. Type summary
  • 15.8.4. Recent developments
• 15.9. Ypsomed
  • 15.9.1. Company details
  • 15.9.2. Financial outlook
  • 15.9.3. Type summary
  • 15.9.4. Recent developments
• 15.10. Others

15 List of Abbreviations

16 Reference Links

17 Conclusion

18 Research Scope